The current evidence linking Rac not only to metastasis and the development of resistance in solid tumors, but also to leukemic infiltration and progression of various hematologic malignancies highlights the need for a better understanding of this key integrator of microenvironmental signals in leukemia and lymphoma. Here, AKT1 is linked to lymphoma.